Impact of the Distribution to Attending Physicians of a Nominative List of Their Patients Not Participating in the Organised Screening of Colorectal Cancer
IDLN
1 other identifier
interventional
48,649
0 countries
N/A
Brief Summary
Objective : to demonstrate that providing to GPs a list of their patients who are not compliant to colorectal cancer screening will 1) enhance patient participation to screening, and 2) decrease the proportion of cancer diagnosed outside the screening organisation. Design : Randomised controlled study, 3 parallel arms. Enrollment: GPs allocated in the 3 groups of the study will be all GPs 1) from the "Loire-Atlantique and Vendée" geographic area (1300 GPs on average) and 2) who have more than 100 patients in their patient list (based on data provided by the Healthcare Insurance System Services). Patients will be eligible to the study depending on their eligibility to the Faecal Occult Blood Test for colorectal cancer screening : 1) they should be older than 50 and younger than 74; 2) they should not have a personal history of colorectal cancer (or history of adenoma bigger than 1 cm) nor a family history of colorectal cancer. Main outcomes measures : Patient participation to colorectal cancer screening, and number of cancers screened in (versus diagnosed outside) the screening procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable colorectal-cancer
Started Aug 2015
Shorter than P25 for not_applicable colorectal-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 21, 2015
CompletedStudy Start
First participant enrolled
August 1, 2015
CompletedFirst Posted
Study publicly available on registry
August 4, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedSeptember 16, 2016
September 1, 2016
1 year
July 21, 2015
September 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient participation rate to colorectal cancer screening
12 months after starting date of the study
Secondary Outcomes (1)
Number of cancers screened in (versus diagnosed outside) the screening procedure.
12 months after starting date of the study
Study Arms (3)
A: nominative list
EXPERIMENTALProviding a list of patients not compliant with CRC sreening General Practitioners allocated to the intervention group (A) will receive: * a nominative list of their patients who were not compliant to colorectal cancer screening. * a document providing general information about colorectal cancer screening
B: general information
ACTIVE COMPARATORProviding general information about CRC screening General Practitioners allocated to group (B) will receive: \- a document providing general information about colorectal cancer screening (but will not receive the nominative list of patients non compliant to colorectal cancer screening)
C: usual practice
NO INTERVENTIONGeneral Practitioners allocated to group (C) will not receive any information (as in usual practice)
Interventions
GPs allocated to the intervention group (A) will receive a list of the patients who are not compliant to colorectal cancer screening, while GPs allocated to the others groups will not receive this information.
Eligibility Criteria
You may qualify if:
- GPs allocated in the 3 groups of the study will be all GPs
- \) from the "Loire-Atlantique and Vendée" geographic area (1300 GPs on average)
- \) who have more than 100 patients in their patient list (based on data provided by the Healthcare Insurance System Services).
You may not qualify if:
- GPs who have less than 100 patients in their patient list
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nantes University Hospitallead
- Public Health Insurancecollaborator
- Université de Nantescollaborator
- Organisms in charge of local cancer screening programs - Francecollaborator
- Local Cancer Registry - Francecollaborator
Related Publications (1)
Rat C, Pogu C, Le Donne D, Latour C, Bianco G, Nanin F, Cowppli-Bony A, Gaultier A, Nguyen JM. Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial. JAMA. 2017 Sep 5;318(9):816-824. doi: 10.1001/jama.2017.11387.
PMID: 28873160DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 21, 2015
First Posted
August 4, 2015
Study Start
August 1, 2015
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
September 16, 2016
Record last verified: 2016-09